Drugs / GSK2789868A
last change Oct 2014 re-read 3 minutes ago

GSK2789868A

Developed for
influenza
Investigated by
GlaxoSmithKline

Trials 1

20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01934127 Aug → Nov 2013 influenza GlaxoSmithKline Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as GSK2789868A ClinicalTrials.gov intervention name — accepted as the source's own label NCT01934127 ↗